| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 407,771 | 417,935 | 429,351 | 487,545 | | Cost of Revenue | 298,356 | 304,364 | 313,725 | 348,149 | | | Gross Profit | 109,415 | 113,571 | 115,626 | 139,396 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 96,886 | 102,568 | 104,730 | 114,988 | | Non Recurring |
-
|
-
|
-
| 379,269 | | Others | 4,082 | 4,226 | 4,795 | 5,006 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,447 | 6,777 | 6,101 | (359,867) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,573 | 135 | (1,107) | (1,390) | | Earnings Before Interest And Taxes | 10,020 | 6,912 | 4,994 | (361,257) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 10,020 | 6,912 | 4,994 | (361,257) | | Income Tax Expense | 4,568 | 3,986 | 3,396 | (68,288) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,452 | 2,926 | 1,598 | (292,969) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,452 | 2,926 | 1,598 | (292,969) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,452 | $2,926 | $1,598 | ($292,969) |
|
0.11% Nasdaq 
Income Statement
